As society globally faces a growing elderly population, age-related conditions such as osteoporosis are coming to the forefront as critical issues. More emphasis needs to be placed on
Over three million people live with kidney disease in the UK. Some will progress to end-stage kidney disease, which is ultimately fatal, without either dialysis or kidney transplant.
Ben Hargreaves finds that patient organisations are providing an increasingly essential role as a linker between patients and the rest of the life sciences industry.
The combined efforts of researchers, investors, and pharmaceutical and biotech companies have resulted in substantial progress in the treatment of major diseases such as cancer, diabetes, a
In the intricate landscape of pharmaceutical advertising, treading the fine line between compliance and legal language regulations is comparable to a delicate tightrope walk.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.